Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

When to order a biopsy to characterise a metastatic relapse in breast cancer.

Foukakis T, Åström G, Lindström L, Hatschek T, Bergh J.

Ann Oncol. 2012 Sep;23 Suppl 10:x349-53.

PMID:
22987990
[PubMed - indexed for MEDLINE]
2.

Discordant expression of hormone receptors and HER2 in breast cancer. A retrospective comparison of primary tumors with paired metachronous recurrences or metastases.

Arapantoni-Dadioti P, Valavanis C, Gavressea T, Tzaida O, Trihia H, Lekka I.

J BUON. 2012 Apr-Jun;17(2):277-83.

PMID:
22740206
[PubMed - indexed for MEDLINE]
3.

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM.

Cancer Treat Rev. 2012 Oct;38(6):708-14. doi: 10.1016/j.ctrv.2011.11.006. Epub 2011 Dec 16.

PMID:
22178456
[PubMed - indexed for MEDLINE]
4.

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact.

Ibrahim T, Farolfi A, Scarpi E, Mercatali L, Medri L, Ricci M, Nanni O, Serra L, Amadori D.

Oncology. 2013;84(3):150-7. doi: 10.1159/000345795. Epub 2012 Dec 19.

PMID:
23257904
[PubMed - indexed for MEDLINE]
5.

Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.

Lindström LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, Hatschek T, Skoog L, Bergh J.

J Clin Oncol. 2012 Jul 20;30(21):2601-8. doi: 10.1200/JCO.2011.37.2482. Epub 2012 Jun 18.

PMID:
22711854
[PubMed - indexed for MEDLINE]
Free Article
6.

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

Thompson AM, Jordan LB, Quinlan P, Anderson E, Skene A, Dewar JA, Purdie CA; Breast Recurrence in Tissues Study Group.

Breast Cancer Res. 2010;12(6):R92. doi: 10.1186/bcr2771. Epub 2010 Nov 8.

PMID:
21059212
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer.

Qu Q, Zong Y, Fei XC, Chen XS, Xu C, Lou GY, Shen KW.

World J Surg Oncol. 2014 Apr 10;12:93. doi: 10.1186/1477-7819-12-93.

PMID:
24721777
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer.

Aurilio G, Monfardini L, Rizzo S, Sciandivasci A, Preda L, Bagnardi V, Disalvatore D, Pruneri G, Munzone E, Della Vigna P, Renne G, Bellomi M, Curigliano G, Goldhirsch A, Nolè F.

Acta Oncol. 2013 Nov;52(8):1649-56. doi: 10.3109/0284186X.2012.754990. Epub 2013 Jan 17.

PMID:
23327413
[PubMed - indexed for MEDLINE]
9.

The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?

Khasraw M, Brogi E, Seidman AD.

Curr Oncol Rep. 2011 Feb;13(1):17-25. doi: 10.1007/s11912-010-0137-9. Review.

PMID:
21053108
[PubMed - indexed for MEDLINE]
10.

Implications of different CA 15-3 levels according to breast cancer subtype at initial diagnosis of recurrent or metastatic breast cancer.

Park S, Ahn HK, Park LC, Hwang DW, Ji JH, Maeng CH, Cho SH, Lee JY, Park KT, Ahn JS, Park YH, Im YH.

Oncology. 2012;82(3):180-7. doi: 10.1159/000336081. Epub 2012 Mar 16.

PMID:
22433564
[PubMed - indexed for MEDLINE]
11.

Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.

Chen X, Yuan Y, Gu Z, Shen K.

Breast Cancer Res Treat. 2012 Aug;134(3):957-67. doi: 10.1007/s10549-012-1990-z. Epub 2012 Feb 28.

PMID:
22370627
[PubMed - indexed for MEDLINE]
12.

Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status.

Penault-Llorca F, Coudry RA, Hanna WM, Osamura RY, Rüschoff J, Viale G.

Breast. 2013 Apr;22(2):200-2. doi: 10.1016/j.breast.2012.12.004. Epub 2013 Jan 24.

PMID:
23352656
[PubMed - indexed for MEDLINE]
13.

Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer.

Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR.

Ann Oncol. 2005 Nov;16(11):1755-61. Epub 2005 Aug 5.

PMID:
16085689
[PubMed - indexed for MEDLINE]
Free Article
14.

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

Munzone E, Botteri E, Sandri MT, Esposito A, Adamoli L, Zorzino L, Sciandivasci A, Cassatella MC, Rotmensz N, Aurilio G, Curigliano G, Goldhirsch A, Nolè F.

Clin Breast Cancer. 2012 Oct;12(5):340-6. doi: 10.1016/j.clbc.2012.07.001.

PMID:
23040002
[PubMed - indexed for MEDLINE]
15.

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

Simmons C, Miller N, Geddie W, Gianfelice D, Oldfield M, Dranitsaris G, Clemons MJ.

Ann Oncol. 2009 Sep;20(9):1499-504. doi: 10.1093/annonc/mdp028. Epub 2009 Mar 18.

PMID:
19299408
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.

Aurilio G, Disalvatore D, Pruneri G, Bagnardi V, Viale G, Curigliano G, Adamoli L, Munzone E, Sciandivasci A, De Vita F, Goldhirsch A, Nolè F.

Eur J Cancer. 2014 Jan;50(2):277-89. doi: 10.1016/j.ejca.2013.10.004. Epub 2013 Nov 21.

PMID:
24269135
[PubMed - indexed for MEDLINE]
17.

Receptor conversion in distant breast cancer metastases.

Hoefnagel LD, van de Vijver MJ, van Slooten HJ, Wesseling P, Wesseling J, Westenend PJ, Bart J, Seldenrijk CA, Nagtegaal ID, Oudejans J, van der Valk P, van der Groep P, de Vries EG, van der Wall E, van Diest PJ.

Breast Cancer Res. 2010;12(5):R75. doi: 10.1186/bcr2645. Epub 2010 Sep 23.

PMID:
20863372
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Biological subtypes of breast cancer: current concepts and implications for recurrence patterns.

Cadoo KA, Fornier MN, Morris PG.

Q J Nucl Med Mol Imaging. 2013 Dec;57(4):312-21. Review.

PMID:
24322788
[PubMed - indexed for MEDLINE]
Free Article
19.

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.

Jensen JD, Knoop A, Ewertz M, Laenkholm AV.

Breast Cancer Res Treat. 2012 Apr;132(2):511-21. doi: 10.1007/s10549-011-1610-3. Epub 2011 Jun 11.

PMID:
21667123
[PubMed - indexed for MEDLINE]
20.

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

Dowsett M, Houghton J, Iden C, Salter J, Farndon J, A'Hern R, Sainsbury R, Baum M.

Ann Oncol. 2006 May;17(5):818-26. Epub 2006 Feb 23.

PMID:
16497822
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk